mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance

被引:28
作者
Meroni, Marica [1 ,2 ]
Longo, Miriam [1 ,3 ]
Erconi, Veronica [1 ]
Valenti, Luca [4 ]
Gatti, Stefano [5 ]
Fracanzani, Anna Ludovica [1 ,2 ]
Dongiovanni, Paola [1 ]
机构
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Gen Med & Metab Dis, I-20122 Milan, Italy
[2] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy
[3] Univ Milan, Dept Clin Sci & Community Hlth, I-20122 Milan, Italy
[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Transfus Ctr Translat Med, I-20122 Milan, Italy
[5] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Preclin Res Ctr, I-20122 Milan, Italy
关键词
NAFLD; fibrosis; HCC; hepatic stellate cells; miR-101-3p; FATTY LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; NONALCOHOLIC STEATOHEPATITIS; INDUCED APOPTOSIS; MICRORNA-101; FIBROSIS; TARGETS; EZH2; IDENTIFICATION; PROLIFERATION;
D O I
10.3390/nu11112597
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Insulin resistance (IR) and microRNAs (miRNAs), which regulate cell-to-cell communication between hepatocytes and hepatic stellate cells (HSCs), may intertwine in nonalcoholic fatty liver disease (NAFLD) pathogenesis. The aim of this study was to evaluate whether epigenetics and environmental factors interact to promote progressive NAFLD during IR. We examined the miRNA signature in insulin receptor haploinsufficient (InsR+/-) and wild-type (wt) HSCs by RNAseq (n = 4 per group). Then, we evaluated their impact in an IR-NASH (nonalcoholic steatohepatitis) model (InsR+/- mice fed standard or methionine choline deficient (MCD) diet, n = 10 per group) and in vitro. InsR+/- HSCs displayed 36 differentially expressed miRNAs (p < 0.05 vs. wt), whose expression was then analyzed in the liver of InsR+/- mice fed an MCD diet. We found that miR-101-3p negatively associated with both InsR+/- genotype and MCD (p < 0.05) and the histological spectrum of liver damage (p < 0.01). miR-101-3p was reduced in InsR+/- hepatocytes and HSCs and even more in InsR+/- cells exposed to insulin (0.33 mu M) and fatty acids (0.25 mM), resembling the IR-NASH model. Conversely, insulin induced miR-101-3p expression in wt cells but not in InsR+/- ones (p < 0.05). In conclusion, IR combined with diet-induced liver injury favors miR-101-3p downregulation, which may promote progressive NAFLD through HSC and hepatocyte transdifferentiation and proliferation.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression
    Qiu, Jiannan
    Wu, Shasha
    Wang, Peng
    Zhou, Yan
    Wang, Zhongxia
    Sun, Yong
    Jiang, Chunping
    HEPATOLOGY INTERNATIONAL, 2023, 17 (02) : 463 - 475
  • [32] Exosomal miR-192-5p secreted by bone marrow mesenchymal stem cells inhibits hepatic stellate cell activation and targets PPP2R3A
    Tan, Jie
    Chen, Mingtao
    Liu, Meng
    Chen, Aifang
    Huang, Min
    Chen, Xiaoli
    Tian, Xia
    Chen, Wei
    JOURNAL OF HISTOTECHNOLOGY, 2023, 46 (04) : 158 - 169
  • [33] miRNA-150-5p promotes hepatic stellate cell proliferation and sensitizes hepatocyte apoptosis during liver fibrosis
    Chen, Wei
    Yan, Xuzhen
    Yang, Aiting
    Xu, Anjian
    Huang, Tao
    You, Hong
    EPIGENOMICS, 2020, 12 (01) : 53 - 67
  • [34] MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1
    Zhang, Xiaoqiang
    He, Xianju
    Liu, Yunbing
    Zhang, Huiqing
    Chen, He
    Guo, Shanxian
    Liang, Yonggang
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 93 : 1065 - 1073
  • [35] miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway
    Chen, Si-Yu
    Chen, Xin
    Zhu, Sai
    Xu, Jin-Jin
    Li, Xiao-Feng
    Yin, Na-Na
    Xiao, Yan-Yan
    Huang, Cheng
    Li, Jun
    MOLECULAR BIOTECHNOLOGY, 2025, 67 (02) : 673 - 688
  • [36] LncRNA SPRY4-IT1 facilitates cell proliferation and angiogenesis of glioma via the miR-101-3p/EZH2/VEGFA signaling axis
    Wang, Ji
    Chen, Yanming
    Wang, Qing
    Xu, Hui
    Jiang, Qianqian
    Wang, Man
    Li, Shenggang
    Chen, Ying
    Wu, Chunwang
    Yu, Pei
    Xiao, Zongyu
    Chen, Wenjin
    Lan, Qing
    CANCER MEDICINE, 2023, 12 (06): : 7309 - 7326
  • [37] Downregulation of RGMA by HIF-1A/miR-210-3p axis promotes cell proliferation in oral squamous cell carcinoma
    Lu, Yingjuan
    Li, Yingru
    Wang, Zhangsong
    Xie, Shule
    Wang, Qing
    Lei, Xinyuan
    Ruan, Yi
    Li, Jinsong
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 112
  • [38] Long noncoding RNA SNHG6 promotes proliferation and angiogenesis of cholangiocarcinoma cells through sponging miR-101-3p and activation of E2F8
    Wang, Huishan
    Wang, Li
    Tang, Lingyu
    Luo, Jing
    Ji, Hao
    Zhang, Wen
    Zhou, Jian
    Li, Quanpeng
    Miao, Lin
    JOURNAL OF CANCER, 2020, 11 (10): : 3002 - 3012
  • [39] miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression
    Fu, Juan
    Wu, Biao
    Zhong, Shaohua
    Deng, Wei
    Lin, Feng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 529 (04) : 922 - 929
  • [40] miR-455-3p Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing HSF1 Expression
    Wei, Song
    Wang, Qi
    Zhou, Haoming
    Qiu, Jiannan
    Li, Changyong
    Shi, Chengyu
    Zhou, Shun
    Liu, Rui
    Lu, Ling
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 16 : 758 - 769